Related Experiment Video
Updated: Aug 14, 2026
14:45
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
Whole-mammal mutagenicity tests: evaluation of five methods
Mutation Research
|May 1, 1980
Summary
Mammalian germ-line mutagenicity tests assess genetic changes like point mutations and chromosome damage. The specific-locus test is best for heritable point mutations, while other methods detect chromosomal events and nondisjunction.
Area of Science:
- Genetics
- Toxicology
- Mammalian mutagenesis
Background:
- Mammalian germ-line mutations are crucial for studying genetic toxicology.
- Assessing mutagenicity in mammals is vital for understanding heritable genetic damage and potential carcinogenicity.
Purpose of the Study:
- To summarize and evaluate five common whole-mammal mutagenicity tests.
- To compare the strengths and limitations of these tests for different genetic endpoints.
- To discuss their utility in assessing heritable mutagenicity and as a prescreen for carcinogenicity.
Main Methods:
- Specific-locus test for heritable point mutations.
- Dominant lethal test for male germ-cell stage sensitivity.
- Heritable translocation test for chromosome breakage.
- Sex-chromosome loss test for female chromosome breakage and nondisjunction.
- In vivo somatic mutation test as a prescreen.
Main Results:
- The specific-locus test is reliable for heritable point mutations.
- Heritable translocation and sex-chromosome loss tests are sensitive for chromosomal events.
- The in vivo somatic mutation test serves as an efficient prescreen.
Conclusions:
- Whole-mammal tests are irreplaceable for assessing heritable mutagenicity due to human metabolic relevance.
- These tests provide a practical approach to understanding complex mammalian germ-cell responses.
- While some tests are time-consuming for carcinogenicity screening, the spot test offers a rapid in vivo alternative.
Related Concept Videos
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...